Annual report [Section 13 and 15(d), not S-K Item 405]

STATEMENTS OF STOCKHOLDERS' EQUITY

v3.25.0.1
STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2021   100,192,562    
Beginning balance at Dec. 31, 2021 $ 300,624,207 $ 100,193 $ 553,472,292 $ (252,948,278)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of common warrants issued in offering (in shares)   10,253,907    
Exercise of common warrants issued in offering $ 8,203,126 $ 10,254 8,192,872  
Options exercised (in shares) 100,000 100,000    
Options exercised $ 0 $ 100 (100)  
Shares elected to be withheld for options exercised (in shares)   (47,506)    
Shares elected to be withheld for options exercised 0 $ (48) 48  
Restricted stock vested (in shares)   1,310,894    
Restricted stock vested 0 $ 1,311 (1,311)  
Shares to cover tax withholdings for restricted stock vested (in shares)   (168,523)    
Shares to cover tax withholdings for restricted stock vested 0 $ (169) 169  
Payments to cover tax withholdings for restricted stock vested, net (521,199)   (521,199)  
Common stock issuance for Stronghold Acquisition (in shares)   21,339,986    
Common stock issuance for Stronghold Acquisition 69,141,555 $ 21,340 69,120,215  
Conversion of mezzanine preferred shares for Stronghold Acquisition (in shares)   42,548,892    
Conversion of mezzanine preferred shares for Stronghold Acquisition 137,858,446 $ 42,549 137,815,897  
Share-based compensation 7,162,231   7,162,231  
Net income 138,635,025     138,635,025
Ending balance (in shares) at Dec. 31, 2022   175,530,212    
Ending balance at Dec. 31, 2022 661,103,391 $ 175,530 775,241,114 (114,313,253)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of common warrants issued in offering (in shares)   4,517,427    
Exercise of common warrants issued in offering 3,613,941 $ 4,517 3,609,424  
Induced exercise of common warrants issued in offering (in shares)   14,512,166    
Induced exercise of common warrants issued in offering 8,687,655 $ 14,512 8,673,143  
Restricted stock vested (in shares)   1,680,232    
Restricted stock vested 0 $ 1,680 (1,680)  
Shares to cover tax withholdings for restricted stock vested (in shares)   (288,152)    
Shares to cover tax withholdings for restricted stock vested 0 $ (287) 287  
Payments to cover tax withholdings for restricted stock vested, net (520,153)   (520,153)  
Performance stock vested (in shares)   (1,170,024)    
Performance stock vested 0 $ 1,170 (1,170)  
Shares to cover tax withholdings for performance stock vested (in shares)   (284,908)    
Shares to cover tax withholdings for performance stock vested 0 $ (285) 285  
Share-based compensation 8,833,425   8,833,425  
Net income 104,864,641     104,864,641
Ending balance (in shares) at Dec. 31, 2023   196,837,001    
Ending balance at Dec. 31, 2023 786,582,900 $ 196,837 795,834,675 (9,448,612)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Restricted stock vested (in shares)   1,688,317    
Restricted stock vested 0 $ 1,688 (1,688)  
Shares to cover tax withholdings for restricted stock vested (in shares)   (327,041)    
Shares to cover tax withholdings for restricted stock vested 0 $ (327) 327  
Payments to cover tax withholdings for restricted stock vested, net (919,249)   (919,249)  
Performance stock vested (in shares)   (571,324)    
Performance stock vested 0 $ 571 (571)  
Shares to cover tax withholdings for performance stock vested (in shares)   (208,223)    
Shares to cover tax withholdings for performance stock vested 0 $ (208) 208  
Share-based compensation 5,506,017   5,506,017  
Net income 67,470,314     67,470,314
Ending balance (in shares) at Dec. 31, 2024   198,561,378    
Ending balance at Dec. 31, 2024 $ 858,639,982 $ 198,561 $ 800,419,719 $ 58,021,702